Library Subscription: Guest
Critical Reviews™ in Neurobiology

Published 3 issues per year

ISSN Print: 0892-0915

ISSN Online: 2375-0014

SJR: 0.121

Dopamine D2 Receptors in Signal Transduction and Behavior

Volume 11, Issue 2-3, 1997, pp. 121-142
DOI: 10.1615/CritRevNeurobiol.v11.i2-3.20
Get accessGet access

ABSTRACT

The dopamine D2 receptor belongs to the family of seven transmembrane domain G-protein-coupled receptors and is highly expressed in the central nervous system and the pituitary gland. The binding of dopamine to the D2 receptor is crucial for the regulation of diverse physiological functions, such as the control of locomotor activity and the synthesis of peptide hormones. Two alternatively spliced transcripts are generated from the D2 receptor gene and code for the D2L and D2S isoforms, which are 444 and 415 amino acids in length, respectively. These isoforms exhibit similar pharmacological characteristics and are expressed in the same cell types, with a ratio that normally favors expression of the longer isoform. The D2L isoform differs from D2S by the insertion of 29 amino acids in the putative third intracellular loop of the receptor. This loop is involved in the coupling of the receptor to different G proteins. Experiments have shown that the D2 isoforms have different G-protein-coupling affinities, suggesting that these receptors might serve different functions in vivo. Additionally, this difference in coupling affinity could be a mechanism to amplify the signal transduced by the binding of dopamine to D2 receptors. Important insights into D2 receptor function in vivo have been obtained by knocking out the D2 gene in mice. The Parkinsonian-like phenotype of D2-null mice demonstrates the importance of the D2 receptor for locomotor function.

CITED BY
  1. Moreno M., Lopez-Moreno J. A., Rodr??guez de Fonseca F., Navarro M., Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats, Behavioural Pharmacology, 16, 5-6, 2005. Crossref

  2. Aoyama Shiro, Kase Hiroshi, Baik Ja-Hyun, Borrelli Emiliana, Knockout Mice in the Study of Dopaminergic Diseases, in Adenosine Receptors and Parkinson's Disease, 2000. Crossref

  3. Dredge B. Kate, Polydorides Alexandros D., Darnell Robert B., The splice of life: Alternative splicing and neurological disease , Nature Reviews Neuroscience, 2, 1, 2001. Crossref

  4. Klein Christine, Gurvich Nadia, Sena-Esteves Miguel, Bressman Susan, Brin Mitchell F., Ebersole Barbara J., Fink Stephen, Forsgren Lars, Friedman Jennifer, Grimes David, Holmgren Gosta, Kyllerman M�rtin, Lang Anthony E., De Leon Deborah, Leung Joanne, Prioleau Cassandra, Raymond Deborah, Sanner Gunnar, Saunders-Pullman Rachel, Vieregge Peter, Wahlstr�m Jan, Breakefield Xandra O., Kramer Patricia L., Ozelius Laurie J., Sealfon Stuart C., Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia, Annals of Neurology, 47, 3, 2000. Crossref

  5. Demchyshyn Lidia, O’Dowd Brian, George Susan, Structure of Mammalian D1 and D5 Dopamine Receptors and Their Function and Regulation in Cells, in Dopamine Receptors and Transporters, 2003. Crossref

  6. Burke Andrew R., Miczek Klaus A., Stress in adolescence and drugs of abuse in rodent models: Role of dopamine, CRF, and HPA axis, Psychopharmacology, 231, 8, 2014. Crossref

  7. Ahmadiantehrani Somayeh, Ron Dorit, Dopamine D2 receptor activation leads to an up-regulation of glial cell line-derived neurotrophic factor via Gβγ-Erk1/2-dependent induction of Zif268, Journal of Neurochemistry, 125, 2, 2013. Crossref

  8. Gingrich Brenden, Liu Yan, Cascio Carissa, Wang Zuoxin, Insel Thomas R., Dopamine D2 receptors in the nucleus accumbens are important for social attachment in female prairie voles (Microtus ochrogaster)., Behavioral Neuroscience, 114, 1, 2000. Crossref

  9. Sim Hye-ri, Choi Tae-Yong, Lee Hyo Jin, Kang Eun Young, Yoon Sehyoun, Han Pyung-Lim, Choi Se-Young, Baik Ja-Hyun, Role of dopamine D2 receptors in plasticity of stress-induced addictive behaviours, Nature Communications, 4, 1, 2013. Crossref

  10. Hakansson Kerstin, Pozzi Laura, Usiello Alessandro, Haycock John, Borrelli Emiliana, Fisone Gilberto, Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol, European Journal of Neuroscience, 20, 4, 2004. Crossref

  11. Khan Shazina S., Lee Frank J. S., Delineation of Domains Within the Cannabinoid CB1 and Dopamine D2 Receptors That Mediate the Formation of the Heterodimer Complex, Journal of Molecular Neuroscience, 53, 1, 2014. Crossref

  12. Viaro Riccardo, Calcagno Mariangela, Marti Matteo, Borrelli Emiliana, Morari Michele, Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands, Neuropharmacology, 72, 2013. Crossref

  13. Ishibashi Kenji, Ishii Kenji, Oda Keiichi, Kawasaki Keiichi, Mizusawa Hidehiro, Ishiwata Kiichi, Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum, Synapse, 63, 4, 2009. Crossref

  14. Bozzi Yuri, Borrelli Emiliana, Absence of the dopamine D2 receptor leads to a decreased expression of GDNF and NT-4 mRNAs in restricted brain areas, European Journal of Neuroscience, 11, 4, 1999. Crossref

  15. Luo Yongquan, Roth George S., The Roles of Dopamine Oxidative Stress and Dopamine Receptor Signaling in Aging and Age-Related Neurodegeneration, Antioxidants & Redox Signaling, 2, 3, 2000. Crossref

  16. LUO YONGQUAN, ROTH GEORGE S., Dopamine Stimulates Astrocytic C6-D2L Cells via Tyrosine Kinase and p38 MAPK Activation, Annals of the New York Academy of Sciences, 899, 1, 2006. Crossref

  17. Koc Erdogan, Boz Hakan, Psychoneurobiochemistry of tourism marketing, Tourism Management, 44, 2014. Crossref

  18. Packeu Ann, De Backer Jean-Paul, Vauquelin Georges, Non-competitive interaction between raclopride and spiperone on human D2L-receptors in intact Chinese hamster ovary cells, Fundamental & Clinical Pharmacology, 24, 3, 2009. Crossref

  19. Packeu Ann, Béghin Tim, De Backer Jean-Paul, Vauquelin Georges, Antagonist-D2S-dopamine receptors interactions in intact Chinese recombinant ovary cells, Fundamental & Clinical Pharmacology, 24, 3, 2009. Crossref

  20. Doehring Alexandra, Hentig Nils von, Graff Jochen, Salamat Syavash, Schmidt Michael, Geisslinger Gerd, Harder Sebastian, Lötsch Jörn, Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution, Pharmacogenetics and Genomics, 19, 6, 2009. Crossref

  21. Doehring Alexandra, Kirchhof Anja, Lötsch Jörn, Genetic diagnostics of functional variants of the human dopamine D2 receptor gene, Psychiatric Genetics, 19, 5, 2009. Crossref

  22. Nord Magdalena, Farde Lars, Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia, CNS Neuroscience & Therapeutics, 17, 2, 2011. Crossref

  23. Koko Vesna, Djordjevic Jelena, Cvijic Gordana, Davidovic Vukosava, Effect of the acute heat stress on the rat pituitary gland. Morphological and stereological study, Journal of Thermal Biology, 31, 5, 2006. Crossref

  24. Gainetdinov Raul R, Bohn Laura M, Sotnikova Tatyana D, Cyr Michel, Laakso Aki, Macrae Alexander D, Torres Gonzalo E, Kim Kyeong-Man, Lefkowitz Robert J, Caron Marc G, Premont Richard T, Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice, Neuron, 38, 2, 2003. Crossref

  25. Saiardi Adolfo, Bozzi Yuri, Baik Ja-Hyun, Borrelli Emiliana, Antiproliferative Role of Dopamine: Loss of D2 Receptors Causes Hormonal Dysfunction and Pituitary Hyperplasia, Neuron, 19, 1, 1997. Crossref

  26. Wu Jing, Xiao Haifan, Sun Hongjuan, Zou Li, Zhu Ling-Qiang, Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis, Molecular Neurobiology, 45, 3, 2012. Crossref

  27. Viggiano Davide, Ruocco Lucia A, Sadile Adolfo G, Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder, Neuroscience & Biobehavioral Reviews, 27, 7, 2003. Crossref

  28. Packeu Ann, De Backer Jean-Paul, Van Liefde Isabelle, Vanderheyden Patrick M.L., Vauquelin Georges, Antagonist-radioligand binding to D2L-receptors in intact cells, Biochemical Pharmacology, 75, 11, 2008. Crossref

  29. Tadori Yoshihiro, Miwa Takashi, Tottori Katsura, Burris Kevin D., Stark Arlene, Mori Toyoki, Kikuchi Tetsuro, Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic, European Journal of Pharmacology, 515, 1-3, 2005. Crossref

  30. Jensen Kirk B, Dredge B.Kate, Stefani Giovanni, Zhong Ru, Buckanovich Ronald J, Okano Hirotaka J, Yang Yolanda Y.L, Darnell Robert B, Nova-1 Regulates Neuron-Specific Alternative Splicing and Is Essential for Neuronal Viability, Neuron, 25, 2, 2000. Crossref

  31. Moreno Margarita, Trigo Jose Manuel, Escuredo Leticia, Rodrı́guez de Fonseca Fernando, Navarro Miguel, Perinatal exposure to Δ9-tetrahydrocannabinol increases presynaptic dopamine D2 receptor sensitivity: a behavioral study in rats, Pharmacology Biochemistry and Behavior, 75, 3, 2003. Crossref

  32. Vallone Daniela, Picetti Roberto, Borrelli Emiliana, Structure and function of dopamine receptors, Neuroscience & Biobehavioral Reviews, 24, 1, 2000. Crossref

  33. Kauffman Alexander S., Buenzle Jennifer, Fraley Gregory S., Rissman Emilie F., Effects of galanin-like peptide (GALP) on locomotion, reproduction, and body weight in female and male mice, Hormones and Behavior, 48, 2, 2005. Crossref

  34. Luo Yongquan, Kokkonen Gertrude C, Hattori Akinori, Chrest Francis J, Roth George S, Dopamine stimulates redox–tyrosine kinase signaling and p38 MAPK in activation of astrocytic C6-D2L cells, Brain Research, 850, 1-2, 1999. Crossref

  35. Wong A H C, Liu F, Uncoupling the Dopamine D1–D2 Receptor Complex: A Novel Target for Antidepressant Treatment, Clinical Pharmacology & Therapeutics, 91, 2, 2012. Crossref

  36. Koehler Saskia, Wacker Jan, Odorfer Thorsten, Reif Andreas, Gallinat Jürgen, Fallgatter Andreas J., Herrmann Martin J., Resting posterior minus frontal EEG slow oscillations is associated with extraversion and DRD2 genotype, Biological Psychology, 87, 3, 2011. Crossref

  37. Millan Mark J., Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application, Pharmacology & Therapeutics, 110, 2, 2006. Crossref

  38. Sidhu Anita, Niznik Hyman B., Coupling of dopamine receptor subtypes to multiple and diverse G proteins, International Journal of Developmental Neuroscience, 18, 7, 2000. Crossref

  39. Heber David, Carpenter Catherine L., Addictive Genes and the Relationship to Obesity and Inflammation, Molecular Neurobiology, 44, 2, 2011. Crossref

  40. Mazzucchelli Cristina, Sassone-Corsi Paolo, The inducible cyclic adenosine monophosphate early repressor (ICER) in the pituitary intermediate lobe: role in the stress response, Molecular and Cellular Endocrinology, 155, 1-2, 1999. Crossref

  41. Sun H., Calipari E.S., Beveridge T.J.R., Jones S.R., Chen R., The brain gene expression profile of dopamine D2/D3 receptors and associated signaling proteins following amphetamine self-administration, Neuroscience, 307, 2015. Crossref

  42. Bryant C. D., Yazdani N., RNA-binding proteins, neural development and the addictions, Genes, Brain and Behavior, 15, 1, 2016. Crossref

  43. Omori Yoshihiro, Chaya Taro, Yoshida Satoyo, Irie Shoichi, Tsujii Toshinori, Furukawa Takahisa, Sato Makoto, Identification of G Protein-Coupled Receptors (GPCRs) in Primary Cilia and Their Possible Involvement in Body Weight Control, PLOS ONE, 10, 6, 2015. Crossref

  44. Klein Christine, Liu Liu, Doheny Dana, Kock Norman, Müller Birgitt, De Carvalho Aguiar Patricia, Leung Joanne, De Leon Deborah, Bressman Susan B., Silverman Jeremy, Smith Christopher, Danisi Fabio, Morrison Chris, Walker Ruth H., Velickovic Miodrag, Schwinger Eberhard, Kramer Patricia L., Breakefield Xandra O., Brin Mitchell F., Ozelius Laurie J., ε-sarcoglycan mutations found in combination with other dystonia gene mutations, Annals of Neurology, 52, 5, 2002. Crossref

  45. Fukada Masahide, Nakayama Atsuo, Mamiya Takayoshi, Yao Tso-Pang, Kawaguchi Yoshiharu, Dopaminergic abnormalities in Hdac6-deficient mice, Neuropharmacology, 110, 2016. Crossref

  46. Brancato Anna, Plescia Fulvio, Marino Rosa Anna Maria, Maniaci Giuseppe, Navarra Michele, Cannizzaro Carla, Hashimoto Kenji, Involvement of Dopamine D2 Receptors in Addictive-Like Behaviour for Acetaldehyde, PLoS ONE, 9, 6, 2014. Crossref

  47. Usiello Alessandro, Baik Ja-Hyun, Rougé-Pont Françoise, Picetti Roberto, Dierich Andrée, LeMeur Marianne, Piazza Pier Vincenzo, Borrelli Emiliana, Distinct functions of the two isoforms of dopamine D2 receptors, Nature, 408, 6809, 2000. Crossref

  48. Miguel Patrícia Maidana, Deniz Bruna Ferrary, Deckmann Iohanna, Confortim Heloísa Deola, Diaz Ramiro, Laureano Daniela Pereira, Silveira Patrícia Pelufo, Pereira Lenir Orlandi, Prefrontal cortex dysfunction in hypoxic-ischaemic encephalopathy contributes to executive function impairments in rats: Potential contribution for attention-deficit/hyperactivity disorder, The World Journal of Biological Psychiatry, 19, 7, 2018. Crossref

  49. Dobbs L. K., Lemos J. C., Alvarez V. A., Restructuring of basal ganglia circuitry and associated behaviors triggered by low striatal D2 receptor expression: implications for substance use disorders, Genes, Brain and Behavior, 16, 1, 2017. Crossref

  50. Tan Eng-King, Tan Yanni, Chai Anthea, Tan Christopher, Shen Hui, Lum Sau-Ying, Fook-Cheong Stephanie M.C., Teoh Mei-Ling, Yih Yuan, Wong Meng-Cheong, Zhao Yi, Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease, Movement Disorders, 18, 5, 2003. Crossref

  51. Mercier David, Falardeau Pierre, L??vesque Daniel, Autoreceptor preference of dopamine D2 receptor agonists correlates with preferential coupling to cyclic AMP, Neuroreport, 12, 7, 2001. Crossref

  52. Millan Mark J., Cussac Didier, Gobert Alain, Lejeune Françoise, Rivet Jean-Michel, La Cour Clotilde Mannoury, Newman-Tancredi Adrian, Peglion Jean-Louis, S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: I. Cellular, Electrophysiological, and Neurochemical Profile in Comparison with Ropinirole, Journal of Pharmacology and Experimental Therapeutics, 309, 3, 2004. Crossref

  53. Kirchheiner Julia, Meisel Christian, Rosenkranz Bernd, Roots Ivar, Besonderheiten der Arzneitherapie im Alter unter Berücksichtigung pharmakogenetischer Faktoren, in Molekularmedizinische Grundlagen von altersspezifischen Erkrankungen, 2004. Crossref

  54. Gille Gabriele, Riederer Peter, Dopamine and Neurodegeneration, in Dopamine and Glutamate in Psychiatric Disorders, 2005. Crossref

  55. Ben-Jonathan Nira, Hnasko Robert, Dopamine as a Prolactin (PRL) Inhibitor, Endocrine Reviews, 22, 6, 2001. Crossref

  56. Jamwal Sumit, Kumar Puneet, Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson’s Disease and Huntington’s Disease: A Review, Current Neuropharmacology, 17, 2, 2019. Crossref

  57. Tan S., Hermann B., Iaccarino C., Omori M., Usiello A., Borrelli E., Understanding the Function of the Dopamine D2 Receptor: A Knockout Animal Approach, in Dopamine in the CNS I, 154 / 1, 2002. Crossref

  58. Tirotta Emanuele, De Mei Claudia, Iitaka Chisato, Ramos Maria, Holmes Dawn, Borrelli Emiliana, Unraveling the Role of Dopamine Receptors In Vivo: Lessons from Knockout Mice, in The Dopamine Receptors, 2010. Crossref

  59. Usiello Alessandro, Iaccarino Ciro, Borrelli Emiliana, Neurobiological Features of Dopamine D2 Receptors, in Catecholamine Research, 53, 2002. Crossref

  60. Mercatelli Daniela, Pisanò Clarissa Anna, Novello Salvatore, Morari Michele, NOP Receptor Ligands and Parkinson’s Disease, in The Nociceptin/Orphanin FQ Peptide Receptor, 254, 2018. Crossref

  61. Gondré-Lewis Marjorie C., Bassey Rosemary, Blum Kenneth, Pre-clinical models of reward deficiency syndrome: A behavioral octopus, Neuroscience & Biobehavioral Reviews, 115, 2020. Crossref

  62. Ciccotosto Giuseppe D., Hand Tracey A., Mains Richard E., Eipper Betty A., Breeding Stock-Specific Variation in Peptidylglycineα-Amidating Monooxygenase Messenger Ribonucleic Acid Splicing in Rat Pituitary1, Endocrinology, 141, 2, 2000. Crossref

  63. Winters Stephen J., Ghooray Dushan T., Yang Rong Q, Holmes Joshua B., O’Brien Andrew RW, Morgan Jay, Moore Joseph P., Dopamine-2 Receptor Activation Suppresses PACAP Expression in Gonadotrophs, Endocrinology, 155, 7, 2014. Crossref

  64. Al-Azzawi Haneen, Yacqub-Usman Kiren, Richardson Alan, Hofland Leo J., Clayton Richard N., Farrell William E., Reversal of Endogenous Dopamine Receptor Silencing in Pituitary Cells Augments Receptor-Mediated Apoptosis, Endocrinology, 152, 2, 2011. Crossref

  65. Radl Daniela, De Mei Claudia, Chen Eric, Lee Hyuna, Borrelli Emiliana, Each Individual Isoform of the Dopamine D2 Receptor Protects from Lactotroph Hyperplasia, Molecular Endocrinology, 27, 6, 2013. Crossref

  66. Cui Hui-Fang, Ye Jian-Shan, Chen Yu, Chong Ser-Choong, Sheu Fwu-Shan, Microelectrode Array Biochip:  Tool for In Vitro Drug Screening Based on the Detection of a Drug Effect on Dopamine Release from PC12 Cells, Analytical Chemistry, 78, 18, 2006. Crossref

  67. Scaplen Kristin M, Petruccelli Emily, Receptors and Channels Associated with Alcohol Use: Contributions from Drosophila, Neuroscience Insights, 16, 2021. Crossref

  68. Kim Chung Sub, Lee Soo-Hyun, Kim Ryang Yeo, Kim Byung-Jin, Li Song-Zhe, Lee In Hye, Lee Eun Jin, Lim Sung-Kil, Bae Yun-Soo, Lee Weontae, Baik Ja-Hyun, Identification of Domains Directing Specificity of Coupling to G-proteins for the Melanocortin MC3 and MC4 Receptors, Journal of Biological Chemistry, 277, 35, 2002. Crossref

  69. Gainetdinov Raul R., Premont Richard T., Bohn Laura M., Lefkowitz Robert J., Caron Marc G., DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS, Annual Review of Neuroscience, 27, 1, 2004. Crossref

  70. Mestiri Souhir, Boussetta Sami, Pakstis Andrew J., Elkamel Sarra, Elgaaied Amel Ben Ammar, Kidd Kenneth K., Cherni Lotfi, Genetic diversity of the North African population revealed by the typing of SNPs in the DRD2/ANKK1 genomic region, Gene, 777, 2021. Crossref

  71. Criswell Susan R, Searles Nielsen Susan, Dlamini Wendy W, Warden Mark N, Perlmutter Joel S, Sheppard Lianne, Moerlein Stephen M, Lenox-Krug Jason, Checkoway Harvey, Racette Brad A, Principal Component Analysis of Striatal and Extrastriatal D2 Dopamine Receptor Positron Emission Tomography in Manganese-Exposed Workers, Toxicological Sciences, 182, 1, 2021. Crossref

  72. Dredge B. Kate, Darnell Robert B., Nova Regulates GABA A Receptor γ2 Alternative Splicing via a Distal Downstream UCAU-Rich Intronic Splicing Enhancer , Molecular and Cellular Biology, 23, 13, 2003. Crossref

  73. Choi Eun-Young, Jeong Dae-won, Park Kye Won, Baik Ja-Hyun, G Protein-Mediated Mitogen-Activated Protein Kinase Activation by Two Dopamine D2 Receptors, Biochemical and Biophysical Research Communications, 256, 1, 1999. Crossref

  74. Jae Kim Sung, Yul Kim Sung, Na Young-Soon, Lee Hyun Jung, Chung Kwang Chul, Baik Ja-Hyun, α-Synuclein enhances dopamine D2 receptor signaling, Brain Research, 1124, 1, 2006. Crossref

  75. Mahmoodkhani Maryam, Ghasemi Maedeh, Derafshpour Leila, Amini Mohammad, Mehranfard Nasrin, Developmental effects of early-life stress on dopamine D2 receptor and proteins involved in noncanonical D2 dopamine receptor signaling pathway in the prefrontal cortex of male rats, Journal of Complementary and Integrative Medicine, 2021. Crossref

  76. Soares-Cunha Carina, Coimbra Barbara, Sousa Nuno, Rodrigues Ana J., Reappraising striatal D1- and D2-neurons in reward and aversion, Neuroscience & Biobehavioral Reviews, 68, 2016. Crossref

  77. Myslivecek Jaromir, Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors, Life, 12, 5, 2022. Crossref

  78. Lindgren Niklas, Usiello Alessandro, Goiny Michel, Haycock John, Erbs Eric, Greengard Paul, Hökfelt Tomas, Borrelli Emiliana, Fisone Gilberto, Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites, Proceedings of the National Academy of Sciences, 100, 7, 2003. Crossref

  79. Yoon Sehyoun, Noh Jai Sung, Choi Se-Young, Baik Ja-Hyun, Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice, Biochemical and Biophysical Research Communications, 393, 2, 2010. Crossref

  80. An Juan Ji, Cho Sang-Rae, Jeong Dae Won, Park Kye Won, Ahn Young Soo, Baik Ja-Hyun, Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumor cells, Molecular and Cellular Endocrinology, 206, 1-2, 2003. Crossref

  81. Caragea Violeta-Maria, Manahan-Vaughan Denise, Bidirectional Regulation of Hippocampal Synaptic Plasticity and Modulation of Cumulative Spatial Memory by Dopamine D2-Like Receptors, Frontiers in Behavioral Neuroscience, 15, 2022. Crossref

  82. Iaccarino Ciro, Samad Tarek A., Mathis Carole, Kercret Henri, Picetti Roberto, Borrelli Emiliana, Control of lactotrop proliferation by dopamine: Essential role of signaling through D2 receptors and ERKs, Proceedings of the National Academy of Sciences, 99, 22, 2002. Crossref

  83. Welter Marc, Vallone Daniela, Samad Tarek A., Meziane Hamid, Usiello Alessandro, Borrelli Emiliana, Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine, Proceedings of the National Academy of Sciences, 104, 16, 2007. Crossref

  84. Rocheville Magalie, Lange Daniela C., Kumar Ujendra, Patel Shutish C., Patel Ramesh C., Patel Yogesh C., Receptors for Dopamine and Somatostatin: Formation of Hetero-Oligomers with Enhanced Functional Activity, Science, 288, 5463, 2000. Crossref

  85. Kim Kyu Seok, Yoon Ye Ran, Lee Hyo Jin, Yoon Sehyoun, Kim Sa-Yong, Shin Seung Woo, An Juan Ji, Kim Min-Seon, Choi Se-Young, Sun Woong, Baik Ja-Hyun, Enhanced Hypothalamic Leptin Signaling in Mice Lacking Dopamine D2 Receptors, Journal of Biological Chemistry, 285, 12, 2010. Crossref

  86. An Juan Ji, Bae Mi-Hyun, Cho Sang Rae, Lee Soo-Hyun, Choi Seong-Hoon, Lee Bae Hwan, Shin Hee-Sup, Kim Yong Nyun, Park Kye Won, Borrelli Emiliana, Baik Ja-Hyun, Altered GABAergic neurotransmission in mice lacking dopamine D2 receptors, Molecular and Cellular Neuroscience, 25, 4, 2004. Crossref

  87. Sanwald Simon, Montag Christian, Kiefer Markus, Cumulative Genetic Score of DRD2 Polymorphisms Is Associated with Impulsivity and Masked Semantic Priming, Journal of Molecular Neuroscience, 72, 8, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain